UB Paderborn / Katalog / Suche / in CDI

Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review

British journal of cancer, 2017-12, Vol.117 (12), p.1743-1752

2017

Link zum Volltext

Verfügbarkeit prüfen

Identifying Distinct Cell Types In Infrapatellar Fat Pad During Osteoarthritis

Osteoarthritis and cartilage, 2023-03, Vol.31, p.S304-S304

2023

Link zum Volltext

Verfügbarkeit prüfen

Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma

Nature communications, 2017-12, Vol.8 (1), p.1922-10, Article 1922

2017

Link zum Volltext

Verfügbarkeit prüfen

The Murine Bladder Supports a Population of Stromal Sca-1+/CD34+/lin- Mesenchymal Stem Cells

PloS one, 2015-11, Vol.10 (11), p.e0141437-e0141437

2015

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta‐analysis

International journal of cancer, 2018-07, Vol.143 (2), p.430-437

2018

Link zum Volltext

Verfügbarkeit prüfen

Compensatory regrowth of the mouse bladder after partial cystectomy

PloS one, 2018-11, Vol.13 (11), p.e0206436

2018

Link zum Volltext

Verfügbarkeit prüfen

Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism

American journal of physiology: Gastrointestinal and liver physiology, 2007-07, Vol.293 (1), p.G308-G318

2007

Link zum Volltext

Verfügbarkeit prüfen

Assessing the benefit of cancer drugs approved by the European Medicines Agency using the European Society for Medical Oncology Magnitude of Clinical Benefit Scale over time

European journal of cancer (1990), 2021-06, Vol.150, p.203-210

2021

Link zum Volltext

Verfügbarkeit prüfen

Increasing survival and growth in larval leopard coral grouper (Plectropomus leopardus) using intensively cultured Parvocalanus crassirostris nauplii

Journal of the World Aquaculture Society, 2020-02, Vol.51 (1), p.171-182

2020

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab alone or with chemotherapy for metastatic non-small-cell lung cancer: A systematic review and network meta-analysis

Critical reviews in oncology/hematology, 2022-05, Vol.173, p.103660-103660, Article 103660

2022

Link zum Volltext

Verfügbarkeit prüfen

A systematic review and network meta-analysis of second-line therapy in hepatocellular carcinoma

Current oncology (Toronto), 2020-12, Vol.27 (6), p.300-306

2020

Link zum Volltext

Verfügbarkeit prüfen

Graft‐Versus‐Host Disease After Simultaneous Pancreas–Kidney Transplantation: A Case Report and Review of the Literature

American journal of transplantation, 2014-11, Vol.14 (11), p.2651-2656

2014

Link zum Volltext

Verfügbarkeit prüfen

Estimating hazard ratios from published Kaplan‐Meier survival curves: A methods validation study

Research synthesis methods, 2019-09, Vol.10 (3), p.465-475

2019

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis

Critical reviews in oncology/hematology, 2020-01, Vol.145, p.102817-102817, Article 102817

2020

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

JAMA network open, 2021-02, Vol.4 (2), p.e2033004-e2033004

2021

Link zum Volltext

Verfügbarkeit prüfen

Application of Mount Pinatubo lahar sand as fine aggregate in controlled low-strength materials

IOP conference series. Materials Science and Engineering, 2020-02, Vol.770 (1), p.12092

2020

Link zum Volltext

Verfügbarkeit prüfen

Examining the relationship between the clinical benefit of oncology drug indications and the time from pan-Canadian Oncology Drug Review (pCODR) recommendation to public reimbursement

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19360-e19360

2020

Link zum Volltext

Verfügbarkeit prüfen

Reassessing the net health benefit (NHB) of FDA approved cancer drugs with evolution of evidence using the American Society of Clinical Oncology Value Framework (ASCO-VF)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.7011-7011

2020

Link zum Volltext

Verfügbarkeit prüfen

P1.01-16 First-Line Pembrolizumab With or Without Chemotherapy in PD-L1 positive NSCLC: A Network Meta-Analysis of Randomized Trials

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S465-S466

2018

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab alone or with chemotherapy for PD-L1 positive NSCLC: A network meta-analysis of randomized trials

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9087-9087

2019

Link zum Volltext

Verfügbarkeit prüfen

Examining the association between oncology drug clinical benefit and the time to public reimbursement

Cancer medicine (Malden, MA), 2022-01, Vol.11 (2), p.380-391

2022

Link zum Volltext

Verfügbarkeit prüfen

FGF23: Mediator of poor prognosis in a sizeable subgroup of patients with castration-resistant prostate cancer presenting with severe hypophosphatemia?

Medical hypotheses, 2014-10, Vol.83 (4), p.482-487

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy (IO) versus non-IO for oncology drugs: Comparing survival benefits (SB) using restricted mean survival time

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6617-6617

2018

Link zum Volltext

Verfügbarkeit prüfen

Commutable whole blood reference materials for hemoglobin A1c validated on multiple clinical analyzers

Clinical chemistry and laboratory medicine, 2019-04, Vol.57 (5), p.648

2019

Link zum Volltext

Verfügbarkeit prüfen

Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment

NMR in biomedicine, 2011-07, Vol.24 (6), p.691-699

2011

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review

Identifying Distinct Cell Types In Infrapatellar Fat Pad During Osteoarthritis

Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma

The Murine Bladder Supports a Population of Stromal Sca-1+/CD34+/lin- Mesenchymal Stem Cells

Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta‐analysis

Compensatory regrowth of the mouse bladder after partial cystectomy

Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism

Assessing the benefit of cancer drugs approved by the European Medicines Agency using the European Society for Medical Oncology Magnitude of Clinical Benefit Scale over time

Increasing survival and growth in larval leopard coral grouper (Plectropomus leopardus) using intensively cultured Parvocalanus crassirostris nauplii

Pembrolizumab alone or with chemotherapy for metastatic non-small-cell lung cancer: A systematic review and network meta-analysis

A systematic review and network meta-analysis of second-line therapy in hepatocellular carcinoma

Graft‐Versus‐Host Disease After Simultaneous Pancreas–Kidney Transplantation: A Case Report and Review of the Literature

Estimating hazard ratios from published Kaplan‐Meier survival curves: A methods validation study

Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Application of Mount Pinatubo lahar sand as fine aggregate in controlled low-strength materials

Examining the relationship between the clinical benefit of oncology drug indications and the time from pan-Canadian Oncology Drug Review (pCODR) recommendation to public reimbursement

Reassessing the net health benefit (NHB) of FDA approved cancer drugs with evolution of evidence using the American Society of Clinical Oncology Value Framework (ASCO-VF)

P1.01-16 First-Line Pembrolizumab With or Without Chemotherapy in PD-L1 positive NSCLC: A Network Meta-Analysis of Randomized Trials

Pembrolizumab alone or with chemotherapy for PD-L1 positive NSCLC: A network meta-analysis of randomized trials

Examining the association between oncology drug clinical benefit and the time to public reimbursement

FGF23: Mediator of poor prognosis in a sizeable subgroup of patients with castration-resistant prostate cancer presenting with severe hypophosphatemia?

Immunotherapy (IO) versus non-IO for oncology drugs: Comparing survival benefits (SB) using restricted mean survival time

Commutable whole blood reference materials for hemoglobin A1c validated on multiple clinical analyzers

Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment

Suchergebnisse filtern